Neuroprotective effect of wogonin: potential roles of inflammatory cytokines

Arch Pharm Res. 2004 Sep;27(9):930-6. doi: 10.1007/BF02975846.

Abstract

Wogonin (5,7-dihydroxy-8-methoxyflavone), an active component originated from the root of Scutellaria baicalensis Georgi, has been reported to possess antioxidant and anti-inflammatory properties. In this study, we investigated the neuroprotective effect of wogonin in a focal cerebral ischemia rat model. Wogonin markedly reduced the infarct volume after 2 h middle cerebral artery occlusion followed by 22 h reperfusion. Wogonin decreased the production of nitric oxide and inflammatory cytokines such as TNF-alpha and IL-6 in lipopolisaccharide-stimulated microglial cells. While wogonin reduced the activity of NF-kappaB, it did not change the activity of mitogen-activated protein kinases family members, p38, ERK and JNK. The lipopolisaccharide-stimulated production of NO and cytokines was significantly blocked by various kinds of NF-kappaB inhibitors such as N-acetyl cysteine, pyrrolidinedithiocarbamate and MG-132. The data may indicate that wogonin has neuroprotective effect by preventing the overactivation of microglial cells, possibly by inactivating NF-kappaB signaling pathway.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / metabolism
  • Cells, Cultured
  • Cytokines / antagonists & inhibitors*
  • Cytokines / physiology*
  • Dose-Response Relationship, Drug
  • Flavanones / pharmacology*
  • Flavanones / therapeutic use
  • Inflammation Mediators / antagonists & inhibitors*
  • Inflammation Mediators / physiology
  • Male
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Cytokines
  • Flavanones
  • Inflammation Mediators
  • Neuroprotective Agents
  • wogonin